Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
clinical trials
life sciences
medical device
4
×
national blog main
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
4
×
san francisco blog main
san francisco top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
national top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
cancer
cancer immunotherapy
drugs
eli lilly
impel neuropharma
investing
messenger rna
migraine
4d molecular therapeutics
What
companies
4
×
drug
fda
ipo
migraine
new
activity
approval
approved
arguments
big
bio
biotech
biotechs
class
club
commercialized
competitors
continued
crop
days
decades
digital
disease
dog
drugs
epidemic
exceeded
fatty
firm
firms
frenzied
group
growing
hasn’t
haul
ipos
joined
known
latest
Language
unset
Current search:
biotech
×
companies
×
" raleigh-durham top stories "
×
" medical device "
×
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M